ALNYLAM PHARMACEUTICALS, INC. Pre-tax Income 2008-2025 | ALNY
Beta
What is ALNYLAM PHARMACEUTICALS, INC.'s current pre-tax income?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual pre-tax income for 2025 was $323.2M, a 185.63% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. pre-tax income for the quarter ending December 31, 2025 was $121.9M.
What was ALNYLAM PHARMACEUTICALS, INC.'s pre-tax income in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual pre-tax income for 2024 was $-377.4M, a 12.95% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s pre-tax income in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual pre-tax income for 2023 was $-433.5M, a 61.53% increase from 2022.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-855.6M
→
FY2025
$323.2M
080910111213141516171819202122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $323.2M | +185.6% | 10-K |
| FY2024 | $-377.4M | +13.0% | 10-K |
| FY2023 | $-433.5M | +61.5% | 10-K |
| FY2022 | $-1.13B | -32.3% | 10-K |
| FY2021 | $-852.1M | +0.4% | 10-K |
| FY2020 | $-855.6M | +3.3% | 10-K |
| FY2019 | $-885.3M | -16.4% | 10-K |
| FY2018 | $-760.7M | -55.0% | 10-K |
| FY2017 | $-490.9M | -19.7% | 10-K |
| FY2016 | $-410.1M | -41.4% | 10-K |
| FY2015 | $-290.1M | +27.6% | 10-K |
| FY2014 | $-400.6M | -335.8% | 10-K |
| FY2013 | $-91.9M | +21.2% | 10-K |
| FY2012 | $-116.6M | -102.2% | 10-K |
| FY2011 | $-57.6M | -34.1% | 10-K |
| FY2010 | $-43.0M | +8.5% | 10-K |
| FY2009 | $-47.0M | -84.1% | 10-K |
| FY2008 | $-25.5M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →